Solomon Joshua, NP
Nurse Practitioner · Merced
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 2
- Since medical school
- 9 years
- Graduated 2017
Offices
2 locations · Merced Intensivist Group Inc · Pulmonary Medicine Associates Medical Group Inc.
Looking this up.
Hospitals listed: Mercy Medical Center · Vibra Hospital of Sacramento. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Solomon Joshua’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Mercy Medical CenterMerced, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.168, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.364, Oct 2024 – Sep 2025
See every measure and the patient survey for Mercy Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 1 worse of 6 measures. Safety: 3 better, 3 the same, 0 worse of 6 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.168 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.364 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.1 (0.11 to 2.09) · 798 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.74 (0.37 to 1.11) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 449 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.5 · 544 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 206 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 1,843 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 5,594 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 5,647 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.53 (0.28 to 4.78) · 763 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.35) · 161 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.96 (0.37 to 3.55) · 791 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.67 (0 to 16.88) · 163 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.84 (0.67 to 9.02) · 115 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.92 (0.46 to 3.38) · 273 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,979 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.764 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 31 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.5 · 477 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 62.8 · 511 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 43.6 · 554 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.8 · 462 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.8 to 8.2) · 152 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.7 (8 to 14.1) · 152 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 196 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (10.2 to 19) · 70 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.4) · 413 cases | No different | Jan 2024 – Dec 2024 |
What patients said (394 patients answered, 11% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 2 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$15,602
Medicare paid this office $15,602 for 61 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $8,563 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $3,400 | $110 |
| Hospital discharge day management, more than 30 minutes | 23 | $1,935 | $81 |
| Advance care planning, first 30 minutes | 14 | $848 | $53 |
Who their Medicare patients are
61 Original Medicare patients in 2024. Average age 77 · 85 and older 33% · Women 69% · Also on Medicaid 30% · Health risk score 2.81. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 66% · Chronic kidney disease 54% · Heart failure 52% · Coronary heart disease 51% · Atrial fibrillation 49% · Depression 44% · COPD 36% · Stroke 36% · Cancer 28% · Dementia 28%.
The office billed $68,406, Medicare allowed $19,911 and paid $15,602; for 191 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 61 | 191 | 77 | 2.81 | $68,406 | $15,602 |
| 2023 | 34 | 41 | 79 | 3.06 | $22,509 | $3,841 |
| 2022 | 53 | 96 | 74 | 2.19 | $36,399 | $8,277 |
| 2021 | 14 | 14 | 76 | 1.96 | $5,614 | $1,237 |
| 2020 | 37 | 207 | 73 | 2.88 | $32,353 | $10,708 |
| 2019 | 99 | 824 | 72 | 3.06 | $120,833 | $44,208 |
| 2018 | 21 | 33 | 71 | 3.89 | $9,460 | $2,707 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $3,143 | $108 |
2022: 2 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $4,448 | $139 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $2,407 | $50 |
2020: 1 service
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 13 | $6,891 | $46 |
2019: 3 services
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 42 | $18,470 | $47 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 46 | $12,851 | $61 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 30 | $6,172 | $47 |
2018: 2 services
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 12 | $1,462 | $112 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 12 | $1,173 | $62 |
Medicaid work
$95 in 2020
Medicaid paid $95 for 15 billed services this clinician did in 2020, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 15 | $95 |
| 2020 | 15 | 1 | 15 | $95 |
| 2019 | 238 | 2 | 31 | $2,700 |
See the largest Medicaid services in earlier years
2019
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 205 | $1,716 |
| New patient visit (30+ min) | 33 | $984 |
Drugs they prescribed that Part D paid
$20,016
Pharmacies billed $20,016 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
497 generic and 55 brand-name prescriptions · $20,016 in drug cost · 122 antibiotic prescriptions to 106 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 14 | $7,524 | $537 |
| Midodrine | 11 | $371 | $34 |
| Pantoprazole | 43 | $223 | $5 |
| Hydralazine | 16 | $196 | $12 |
| Amoxicillin-Clavulanate Potass | 30 | $154 | $5 |
See all 17 drugs
| Eliquis | 14 | $7,524 | $537 |
| Midodrine | 11 | $371 | $34 |
| Pantoprazole | 43 | $223 | $5 |
| Hydralazine | 16 | $196 | $12 |
| Amoxicillin-Clavulanate Potass | 30 | $154 | $5 |
| Nitroglycerin | 18 | $108 | $6 |
| Atorvastatin | 22 | $105 | $5 |
| Methylprednisolone | 16 | $78 | $5 |
| Levofloxacin | 18 | $64 | $4 |
| Clopidogrel | 12 | $63 | $5 |
| Cephalexin | 22 | $60 | $3 |
| Metoprolol | 11 | $60 | $5 |
| Tamsulosin | 11 | $58 | $5 |
| Ibuprofen | 18 | $51 | $3 |
| Furosemide | 18 | $50 | $3 |
| Potassium Chloride | 13 | $36 | $3 |
| Azithromycin | 12 | $35 | $3 |
Year by year
| 2024 | 552 | 234 | None | 10% | $20,016 |
| 2023 | 123 | 40 | None | None | $9,233 |
| 2022 | 194 | 37 | None | 7% | $6,363 |
| 2021 | 459 | 46 | None | None | $18,228 |
| 2020 | 1,232 | 52 | 2% (18) | 25% | $58,745 |
| 2019 | 1,285 | 78 | 4% (57) | 15% | $49,173 |
| 2018 | 132 | 15 | None | 21% | $4,613 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Scopolamine | 15 | $428 | $29 |
| Hydralazine | 12 | $194 | $16 |
2022: 4 drugs
| Sevelamer Carbonate | 14 | $1,875 | $134 |
| Scopolamine | 12 | $356 | $30 |
| Hydralazine | 13 | $238 | $18 |
| Amlodipine Besylate | 12 | $69 | $6 |
2021: 13 drugs
| Eliquis | 31 | $3,875 | $125 |
| Symbicort | 11 | $3,098 | $282 |
| Xarelto | 20 | $2,397 | $120 |
| Scopolamine | 19 | $623 | $33 |
| Heparin | 14 | $362 | $26 |
| Pantoprazole | 21 | $229 | $11 |
| Atorvastatin | 22 | $201 | $9 |
| Potassium Chloride | 15 | $144 | $10 |
| Amlodipine Besylate | 22 | $132 | $6 |
| Carvedilol | 13 | $105 | $8 |
| Sertraline | 11 | $102 | $9 |
| Lisinopril | 17 | $96 | $6 |
| Furosemide | 12 | $57 | $5 |
2020: 40 drugs
| Eliquis | 78 | $9,560 | $123 |
| Symbicort | 26 | $6,906 | $266 |
| Xarelto | 47 | $6,123 | $130 |
| Anoro Ellipta | 49 | $5,222 | $107 |
| Myrbetriq | 25 | $4,567 | $183 |
| Novolog Flexpen | 22 | $2,686 | $122 |
| Scopolamine | 57 | $2,498 | $44 |
| Memantine Hcl Er | 21 | $1,049 | $50 |
| Atorvastatin | 68 | $760 | $11 |
| Pantoprazole | 52 | $675 | $13 |
| Theophylline | 13 | $664 | $51 |
| Novofine Autocover | 23 | $621 | $27 |
| Levetiracetam | 26 | $586 | $23 |
| Esomeprazole Magnesium | 16 | $545 | $34 |
| Amantadine | 13 | $511 | $39 |
| Potassium Chloride | 35 | $464 | $13 |
| Baclofen | 21 | $433 | $21 |
| Metoprolol | 19 | $322 | $17 |
| Levothyroxine | 23 | $310 | $13 |
| Nystatin | 13 | $284 | $22 |
| Megestrol Acetate | 11 | $262 | $24 |
| Alendronate | 36 | $250 | $7 |
| Sertraline | 26 | $236 | $9 |
| Oxybutynin Chloride | 14 | $220 | $16 |
| Benztropine Mesylate | 13 | $201 | $15 |
| Clopidogrel | 19 | $186 | $10 |
| Carvedilol | 25 | $172 | $7 |
| Tamsulosin | 12 | $167 | $14 |
| Metoprolol | 17 | $151 | $9 |
| Buspirone | 13 | $148 | $11 |
| Sodium Chloride | 15 | $146 | $10 |
| Ranitidine | 15 | $146 | $10 |
| Furosemide | 31 | $138 | $4 |
| Lisinopril | 25 | $137 | $5 |
| Methotrexate | 11 | $121 | $11 |
| Irbesartan | 17 | $121 | $7 |
| Escitalopram | 13 | $91 | $7 |
| Amlodipine Besylate | 16 | $78 | $5 |
| Finasteride | 14 | $76 | $5 |
| Amiodarone | 11 | $74 | $7 |
2019: 38 drugs
| Myrbetriq | 21 | $4,387 | $209 |
| Symbicort | 15 | $3,818 | $255 |
| Potassium Chloride | 43 | $1,482 | $34 |
| Scopolamine | 31 | $1,313 | $42 |
| Sevelamer Carbonate | 12 | $929 | $77 |
| Atorvastatin | 88 | $848 | $10 |
| Itraconazole | 13 | $824 | $63 |
| Heparin | 16 | $537 | $34 |
| Levetiracetam | 20 | $524 | $26 |
| Sodium Chloride | 23 | $409 | $18 |
| Theophylline | 12 | $392 | $33 |
| Pantoprazole | 28 | $360 | $13 |
| Carvedilol | 34 | $327 | $10 |
| Oxybutynin Chloride | 17 | $281 | $17 |
| Hydrocodone-Acetaminophen | 30 | $238 | $8 |
| Furosemide | 40 | $228 | $6 |
| Sertraline | 23 | $226 | $10 |
| Metoprolol | 19 | $224 | $12 |
| Baclofen | 18 | $220 | $12 |
| Amlodipine Besylate | 49 | $212 | $4 |
| Lisinopril | 36 | $207 | $6 |
| Gabapentin | 17 | $191 | $11 |
| Spironolactone | 14 | $182 | $13 |
| Clopidogrel | 24 | $172 | $7 |
| Metoprolol | 19 | $146 | $8 |
| Famotidine | 16 | $130 | $8 |
| Alendronate | 26 | $128 | $5 |
| Tizanidine | 19 | $123 | $6 |
| Montelukast | 11 | $118 | $11 |
| Metronidazole | 15 | $108 | $7 |
| Ibuprofen | 13 | $104 | $8 |
| Irbesartan | 11 | $104 | $9 |
| Hydralazine | 12 | $87 | $7 |
| Meloxicam | 14 | $83 | $6 |
| Tramadol | 16 | $76 | $5 |
| Metformin | 13 | $71 | $5 |
| Omeprazole | 12 | $51 | $4 |
| Losartan | 14 | $50 | $4 |
2018: 1 drug
| Piperacillin-Tazobactam | 15 | $387 | $26 |
Money from drug and device companies
$91 in 2025
| 2025 | 3 | 3 | None | $91 |
| 2022 | 1 | 1 | None | $14 |
| 2021 | 1 | 1 | None | $14 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Merck Sharp & Dohme | Zerbaxa | $34 | 1 payment
|
| Abbvie | Emblaveo | $30 | 1 payment
|
| Ardelyx | Ibsrela | $28 | 1 payment
|
See all 3 published payments
| Merck Sharp & Dohme | Meals · 2025-10-24 | Zerbaxa | $34 |
| Ardelyx | Meals · 2025-07-03 | Ibsrela | $28 |
| Abbvie | Meals · 2025-06-24 | Emblaveo | $30 |
See earlier years (2022, 2021)
2022: $14
| Lucid Diagnostics | None | $14 | 1 payment
|
2021: $14
| Tactile Systems Technology | Flexitouch Plus | $14 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 99.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1922502053
- Licence
- NV APRN002841
- Group
- Merced Intensivist Group Inc · Pulmonary Medicine Associates Medical Group Inc.
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2018-03-22
- NPI last updated
- 2025-04-30
- NPI record certified
- 2025-04-30
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1300 Ethan Way Ste 600, Sacramento, CA, 95825